Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Godavari Drugs Ltd
Your Vote -
Buy
66.67%
Hold
0.00%
Sell
33.33%
66.67%
3 users have voted
Option Chain
Analyzes market sentiment, predicts Godavari Drugs Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Godavari Drugs Q4 net profit jumps 44.94% at Rs 1.29 cr
-
Godavari Drugs - Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue For The Quarte
-
Godavari Drugs - Financial Results For Period Ended 31St March,2026
-
Godavari Drugs - Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On Wednesday 27Th Day Of M
-
Godavari Drugs - Board Meeting Intimation for Board Meeting Intimation For The Fourth Quarter And Financial Year Ended March
-
Godavari Drugs has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Godavari Drugs - Clarification On Price Movement
-
Godavari Drugs - Clarification sought from Godavari Drugs Ltd
-
Godavari Drugs has submitted to BSE the Shareholding Pattern for the Period Ended March 18, 2026
-
Godavari Drugs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Godavari Drugs - Board Meeting Outcome for Outcome Of Board Meeting Held On 18Th March, 2026.
Key fundamentals
Evaluate the intrinsic value of Godavari Drugs Ltd stock
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 152.1573 | 104.9738 | 94.5909 | 66.9135 | 49.9747 |
| Liabilities | 152.1573 | 104.9738 | 94.5909 | 66.9135 | 49.9747 |
| Equity | 10.1274 | 7.5305 | 7.5305 | 7.5305 | 7.5305 |
| Gross Profit | 10.3146 | 11.8278 | 13.3043 | 9.9208 | 11.29 |
| Net Profit | 4.0891 | 4.38 | 5.5489 | 3.7858 | 5.2453 |
| Cash From Operating Activities | 0.7335 | 11.196 | 18.4136 | 13.2171 | 11.2298 |
| NPM(%) | 3.86 | 3.86 | 3.54 | 2.37 | 3.25 |
| Revenue | 105.8081 | 113.3501 | 156.7119 | 159.6248 | 161.1062 |
| Expenses | 95.4935 | 101.5223 | 143.4076 | 149.704 | 149.8162 |
| ROE(%) | 8.38 | 8.98 | 11.38 | 7.76 | 10.76 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Godavari Drugs Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 704.30 | -2.42 | 0.00 | 72.54 | -26.19 | 0.71 |
| Lotus Eye Hospital and Institute Ltd | 108.05 | -1.05 | 3619.00 | 264.32 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 17.50 | -1.30 | 0.00 | 548.82 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 770.75 | 1.41 | 0.00 | 249.26 | -363.15 | 0.00 |
Company Info
GODAVARI DRUGS LIMITED was incorporated as a private limited company on December 2nd 1987 and subsequently converted into a public limited company on September 25th 1992. It was promoted by Mr. Ghanshyam Jaju, Mr. Mukund Kakani and Mr. P.C. Shrimal. The company has set up a project to manufacture 180 TPA at SULPHAMETHOXAZOLE (SMX) in 1988. The project is located at Maharashtra Industrial Development Corporation (MIDC), Nanded, a notified class 'C' backward district in Maharashtra. The project was fully commissioned on July 3rd 1989. MAIN OBJECTS OF THE COMPANY: The main objects at the Company as detailed in the Memorandum at Association of the Company are: 1. To manufacture, refine, purchase, sell, prepare, import, export all classes and kinds of drugs including pharmaceutical preparations and formulations, fine organics and inorganic chemicals, raw materials and intermediates for drugs. 2. To manufacture and/or deal in all types at drugs, chemicals, pharmaceuticals and intermediates on loan licence basis. 3. To undertake, promote, encourage, initiate, assist and engage in all kinds of research and development work and to set up laboratories and other facilities required for the same to render such assistance, monetary or otherwise, as may be required for the purpose. 2012 -Godavari Drugs Ltd has informed that the Board has appointed Mr. Mohit Jaju as an Additional Director effective from May 10, 2012
GODAVARI DRUGS LIMITED was incorporated as a private limited company on December 2nd 1987 and subsequently converted into a public limited company on September 25th 1992. It was promoted by Mr. Ghanshyam Jaju, Mr. Mukund Kakani and Mr. P.C. Shrimal. The company has set up a project to manufacture 180 TPA at SULPHAMETHOXAZOLE (SMX) in 1988. The project is located at Maharashtra Industrial Development Corporation (MIDC), Nanded, a notified class 'C' backward district in Maharashtra. The project was fully commissioned on July 3rd 1989. MAIN OBJECTS OF THE COMPANY: The main objects at the Company as detailed in the Memorandum at Association of the Company are: 1. To manufacture, refine, purchase, sell, prepare, import, export all classes and kinds of drugs including pharmaceutical preparations and formulations, fine organics and inorganic chemicals, raw materials and intermediates for drugs. 2. To manufacture and/or deal in all types at drugs, chemicals, pharmaceuticals and intermediates on loan licence basis. 3. To undertake, promote, encourage, initiate, assist and engage in all kinds of research and development work and to set up laboratories and other facilities required for the same to render such assistance, monetary or otherwise, as may be required for the purpose. 2012 -Godavari Drugs Ltd has informed that the Board has appointed Mr. Mohit Jaju as an Additional Director effective from May 10, 2012
Read More
Parent Organisation
Godavari Drugs Ltd.
Founded
02/12/1987
Managing Director
Mr.Mukund Kakani
NSE Symbol
FAQ
The current price of Godavari Drugs Ltd is
The 52-week high for Godavari Drugs Ltd is
The market capitalization of Godavari Drugs Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Godavari Drugs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Godavari Drugs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Godavari Drugs Ltd shares.
The CEO of Godavari Drugs Ltd is Mr.Mukund Kakani, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
